July 26 2022 Healthcare & Life Sciences Limited to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update
June 13 2022 Healthcare & Life Sciences Limited Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development
May 25 2022 Healthcare & Life Sciences Limited Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China
May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences
April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update
April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update
April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress
March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference
March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2
March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update
February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update
February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100
February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference
January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement
January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial
January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences
December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent
December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress
December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress
November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress
November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent
November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences
November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update
November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine
November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update
October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe
October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent
September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly
August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021
August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update
August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update
July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting
June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit
May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update
May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021
April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update
April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent
March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update
March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference
March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update
March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio
March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference
March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021
February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering
February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering
January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development
January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update
October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update
October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma
October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development
September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine
September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection
August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer
August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients
August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines
August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update
June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines
June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research
June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market
May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update
April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development
March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act
March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update
March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program
March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program
February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial
January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine
December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference
November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure
November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update
October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV
October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences
October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure
September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer
September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results
August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress
July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency
July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study
July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data
May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019
May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11
May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference
May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress
March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science
March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards
February 06 2019 Healthcare & Life Sciences Limited CEO David Dodd Responds to President Trump’s State of the Union Message
January 24 2019 Healthcare & Life Sciences Limited Zika Vaccine Study Published in the Atlas of Science
January 02 2019 Healthcare & Life Sciences Limited and Enesi Pharma to Collaborate On Development of Multiple Vaccines Administered by ImplaVax® a Novel Needle-Free Vaccine Delivery Platform
November 19 2018 Healthcare & Life Sciences Limited and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program
November 13 2018 Healthcare & Life Sciences Limited and Virometix to Collaborate on Immunotherapy Program for HPV Infections and Related Cancers
November 08 2018 Healthcare & Life Sciences Limited Reports 2018 Third Quarter Financial Results and Provides Corporate Update
November 05 2018 New Study Suggests Zika Virus Eradication in the Americas May Become Impossible, Making the Need for a Vaccine Even More Critical
October 24 2018 Healthcare & Life Sciences Limited Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference
October 18 2018 Healthcare & Life Sciences Limited to Present at Three Upcoming Scientific Conferences
September 27 2018 Healthcare & Life Sciences Limited Observes National Gay Men’s HIV/AIDS Awareness Day
September 26 2018 Healthcare & Life Sciences Limited Awarded $2.4 Million from U.S. Department of Defense to Advance Lassa Fever Vaccine
September 24 2018 Healthcare & Life Sciences Limited Comments on Age-Associated HIV Infection Trends in the U.S.
September 19 2018 Healthcare & Life Sciences Limited Comments on Recent Vaccine Development Study Funded by the Gates Foundation
September 12 2018 Healthcare & Life Sciences Limited to Report Vaccine Development Progress at the 12th Vaccine Congress in Budapest
August 23 2018 Healthcare & Life Sciences Limited Comments on Recent Paper Addressing Safety Concerns Over Ebola Vaccines Under Development
August 21 2018 Healthcare & Life Sciences Limited and PharmaJet to Collaborate On Development of Needle-Free Vaccine for Zika Virus
August 14 2018 Healthcare & Life Sciences Limited Announces Appointment of David Dodd as Chairman, President and Chief Executive Officer
August 07 2018 Healthcare & Life Sciences Limited Reports 2018 Second Quarter Financial Results and Provides Corporate Update
July 30 2018 Healthcare & Life Sciences Limited and Emory University to Collaborate On HPV Therapeutic Program for Head and Neck Cancers
July 09 2018 Healthcare & Life Sciences Limited to Present at the American Society for Virology 2018 Annual Meeting
May 22 2018 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 4-7
May 03 2018 Healthcare & Life Sciences Limited Reports 2018 First Quarter Financial Results and Development Program Updates
April 19 2018 Healthcare & Life Sciences Limited to Present its MVA Vector Platform Technology at Vaccinology Conference
April 10 2018 Healthcare & Life Sciences Limited Awarded NIH Fast Track Phase I/II Grant to Advance Lassa Fever Vaccine
April 05 2018 Healthcare & Life Sciences Limited Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
March 26 2018 Healthcare & Life Sciences Limited’s Chief Scientific Officer to Speak at World Vaccine Congress
February 07 2018 Healthcare & Life Sciences Limited and CaroGen to Collaborate On Development of Therapeutic Hepatitis B Vaccine
January 16 2018 Healthcare & Life Sciences Limited Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports
January 03 2018 Healthcare & Life Sciences Limited and Vaxeal to Collaborate on Cancer Immunotherapy Program
January 02 2018 Healthcare & Life Sciences Limited to Present During China Showcase at Biotech Showcase 2018
